Skip to main content

Want a detailed portfolio tracker?

Aura Biosciences (AURA) P/E (2021 - 2026)

Aura Biosciences (AURA) P/E from Dec 31, 2021 to Jul 20, 2026. The TTM Aura Biosciences (AURA) P/E is -3.79. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Aura Biosciences (AURA)

YearP/EChange
2026-3.79+25.14%
2025-3.03-35.60%
2024-4.70-0.97%
2023-4.75-16.75%
2022-5.71-86.62%
2021-42.65N/A

Comparison Aura Biosciences (AURA) P/E with competitors

Aura Biosciences (AURA) P/E is -3.79.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.04%
NBYStablecoin Development Corp0.00-100.11%
ENLVEnlivex Ltd0.07-101.97%
FGENFibroGen Inc0.24-106.33%
CHRSCoherus Biosciences Inc0.85-122.39%
FBIOFortress Biotech Inc0.95-125.04%
ORMPOramed Pharmaceuticals Inc1.50-139.65%
AGENAgenus Inc3.01-179.40%
INVAInnoviva Inc3.15-183.21%
VXRTVaxart Inc3.55-193.65%
CRMDCorMedix Inc3.63-195.72%
CVACCureVac N.V.4.45-217.28%
GLPGGalapagos NV4.86-228.18%
SRPTSarepta Therapeutics Inc4.88-228.80%
ABEOAbeona Therapeutics Inc5.39-242.13%
ABUSArbutus Biopharma Corp5.60-247.62%
ZVRAZevra Therapeutics Inc5.89-255.31%
SPROSpero Therapeutics Inc6.23-264.31%
CGENCompugen Ltd6.31-266.57%
RIGLRigel Pharmaceuticals6.87-281.29%
SLXNSilexion Therapeutics Corp7.30-292.48%
OMEROmeros Corporation9.26-344.26%
AUPHAurinia Pharmaceuticals Inc9.58-352.86%
PLXProtalix BioTherapeutics Inc10.89-387.32%
ACADAcadia Pharmaceuticals Inc11.73-409.41%
TBPHTheravance Biopharma Inc12.26-423.49%
ADMAAdma Biologics Inc12.42-427.61%
HRMYHarmony Biosciences Holdings Inc13.82-464.59%
SABSSAB Biotherapeutics Inc14.14-472.93%
NAGENiagen Bioscience Inc14.82-490.92%
INCYIncyte Corp15.82-517.42%
REGNRegeneron Pharmaceuticals Inc15.86-518.32%
PBYIPuma Biotechnology Inc17.32-556.81%
CPRXCatalyst Pharmaceuticals Inc17.44-560.07%
EXELExelixis Inc17.54-562.67%
TGTXTG Therapeutics Inc18.97-600.35%
MDXGMimedx Group Inc20.55-642.20%
XOMAXOMA Royalty Corp22.87-703.48%
ARGXArgen X SE24.30-741.03%
CTMXCytomX Therapeutics Inc24.82-754.83%
XOMAOXOMA Royalty Corp25.34-768.65%
HALOHalozyme Therapeutics Inc25.62-776.00%
XOMAPXOMA Royalty Corp25.67-777.23%
VRTXVertex Pharmaceuticals Inc27.99-838.56%
RPRXRoyalty Pharma plc - Class A28.69-856.83%
SLNOSoleno Therapeutics Inc29.02-865.48%
ASNDAscendis Pharma A/S30.09-893.72%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1100.19%
APLSApellis Pharmaceuticals Inc39.02-1129.46%
BMRNBiomarin Pharmaceutical Inc42.21-1213.63%
KRYSKrystal Biotech Inc45.34-1296.25%
ONCBeiGene Ltd69.54-1934.61%
PHARPharming Group N.V.75.03-2079.32%
TECHBio-Techne Corp101.96-2789.86%
VCELVericel Corp109.92-2999.94%
ALNYAlnylam Pharmaceuticals Inc117.96-3212.15%
GMABGenmab140.29-3801.14%
TLXTelix Pharmaceuticals Ltd162.15-4377.91%
CORTCorcept Therapeutics Inc212.86-5715.60%